Free Trial

Crescita Therapeutics (CTX) Competitors

Crescita Therapeutics logo
C$0.54 0.00 (0.00%)
As of 05/23/2025 03:44 PM Eastern

CTX vs. VIR, ZOM, META, DB, VM, NRTH, CWEB, MRV, FLWR, and MPH

Should you be buying Crescita Therapeutics stock or one of its competitors? The main competitors of Crescita Therapeutics include Viridium Pacific Group (VIR), Zomedica Pharmaceuticals Corp. (ZOM.V) (ZOM), Meta Growth (META), Decibel Cannabis (DB), Voyageur Pharmaceuticals (VM), 48North Cannabis (NRTH), Charlotte's Web (CWEB), Nuvo Pharmaceuticals (MRV), Flowr (FLWR), and Medicure (MPH). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Crescita Therapeutics vs.

Viridium Pacific Group (CVE:VIR) and Crescita Therapeutics (TSE:CTX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, community ranking, analyst recommendations, valuation, dividends, risk, profitability, earnings and media sentiment.

Viridium Pacific Group has a net margin of 0.00% compared to Crescita Therapeutics' net margin of -15.73%. Viridium Pacific Group's return on equity of 0.00% beat Crescita Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Viridium Pacific GroupN/A N/A N/A
Crescita Therapeutics -15.73%-15.60%-8.26%

Crescita Therapeutics received 20 more outperform votes than Viridium Pacific Group when rated by MarketBeat users. However, 83.33% of users gave Viridium Pacific Group an outperform vote while only 67.42% of users gave Crescita Therapeutics an outperform vote.

CompanyUnderperformOutperform
Viridium Pacific GroupOutperform Votes
40
83.33%
Underperform Votes
8
16.67%
Crescita TherapeuticsOutperform Votes
60
67.42%
Underperform Votes
29
32.58%

Crescita Therapeutics has higher revenue and earnings than Viridium Pacific Group. Crescita Therapeutics is trading at a lower price-to-earnings ratio than Viridium Pacific Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Viridium Pacific GroupC$1.09M34.46-C$12.64M-C$0.13-2.97
Crescita TherapeuticsC$16.62M0.60-C$2.61M-C$0.15-3.67

In the previous week, Viridium Pacific Group's average media sentiment score of 0.00 beat Crescita Therapeutics' score of -0.68 indicating that Viridium Pacific Group is being referred to more favorably in the media.

Company Overall Sentiment
Viridium Pacific Group Neutral
Crescita Therapeutics Negative

Summary

Viridium Pacific Group beats Crescita Therapeutics on 8 of the 11 factors compared between the two stocks.

Get Crescita Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CTX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CTX vs. The Competition

MetricCrescita TherapeuticsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$9.94MC$2.17BC$5.33BC$5.94B
Dividend YieldN/A2.92%5.20%6.32%
P/E Ratio-3.674.0126.7229.42
Price / Sales0.60569.73395.56926.00
Price / Cash1.2010.2538.3283.58
Price / Book0.657.026.764.02
Net Income-C$2.61MC$20.70BC$3.23BC$300.67M
7 Day Performance5.88%-0.35%0.41%0.92%
1 Month Performance-5.26%3.42%9.12%6.92%
1 Year Performance14.89%96.10%18.73%17.28%

Crescita Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CTX
Crescita Therapeutics
N/AC$0.54
flat
N/A+14.9%C$9.94MC$16.62M-3.6762Gap Down
VIR
Viridium Pacific Group
N/AC$0.38
+5.6%
N/A+0.0%C$37.52MC$1.09M-2.97580Gap Up
ZOM
Zomedica Pharmaceuticals Corp. (ZOM.V)
N/AC$0.29
-6.6%
N/A+0.0%C$36.73MN/A-2.6150Gap Down
META
Meta Growth
N/AC$0.14
flat
N/A+0.0%C$33.14MC$60.96M-0.6686,500Gap Down
DB
Decibel Cannabis
1.205 of 5 stars
C$0.07
-7.1%
C$0.28
+335.9%
-30.0%C$26.59MC$105.60M-6.5083,000News Coverage
Gap Down
VM
Voyageur Pharmaceuticals
N/AC$0.16
-5.9%
N/A+240.0%C$24.24MN/A-14.97N/AGap Up
NRTH
48North Cannabis
N/AC$0.07
-6.7%
N/A+0.0%C$15.76MC$18.90M-0.3047
CWEB
Charlotte's Web
N/AC$0.14
+12.0%
N/A-44.7%C$15.53MC$38.50M-0.43164News Coverage
Gap Up
MRV
Nuvo Pharmaceuticals
N/AN/AN/AN/AC$15.38MC$72.42M-19.29N/A
FLWR
Flowr
N/AC$0.03
flat
N/A+0.0%C$10.66MC$12.92M-0.12186
MPH
Medicure
N/AC$1.00
+14.9%
N/A-10.5%C$10.44MC$21.08M-5.13N/AGap Up

Related Companies and Tools


This page (TSE:CTX) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners